GMAB

GENMAB A/S -SP ADR

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

GENMAB A/S -SP ADR (GMAB) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$193.39M; the largest are Renaissance Technologies, Ken Griffin, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 2 new, 1 added, 1 trimmed. 11 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Heating up

Common-stock holders41 also report options

Congress trades11

Price$35.57vs quarter-end+29.49%

Sectors0

This quarter's moves

New2

Added1

Trimmed / sold1

Top holder

Renaissance Technologies

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Investor	Period	Value	Shares	% of portfolio	Action

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—

Value $8.58M— of portfolio312,3002026 Q2

Ken GriffinPUT—

Value $1.24M— of portfolio45,3002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinCALL	2026 Q2	$8.58M	312,300	—	—
Ken GriffinPUT	2026 Q2	$1.24M	45,300	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.